4//SEC Filing
Nicholson Nur 4
Accession 0001127602-24-010127
CIK 0001492422other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:17 PM ET
Size
6.7 KB
Accession
0001127602-24-010127
Insider Transaction Report
Form 4
Nicholson Nur
Chief Technical Officer
Transactions
- Sale
Common Stock
2024-03-13$57.31/sh−7,768$445,161→ 59,739 total - Sale
Common Stock
2024-03-13$58.13/sh−3,452$200,677→ 56,287 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $56.91 - $57.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $57.92 - $58.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001827317
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:17 PM ET
- Size
- 6.7 KB